Works by Adkins, Douglas


Results: 61
    1
    2
    3

    nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial.

    Published in:
    2021
    By:
    • Oppelt, Peter;
    • Ley, Jessica;
    • Daly, Mackenzie;
    • Rich, Jason;
    • Paniello, Randal;
    • Jackson, Ryan S.;
    • Pipkorn, Patrik;
    • Liu, Jingxia;
    • Gay, Hiram;
    • Palka, Kevin;
    • Neupane, Prakash;
    • Powell, Steven;
    • Spanos, William C.;
    • Gitau, Mark;
    • Zevallos, Jose;
    • Thorstad, Wade;
    • Adkins, Douglas
    Publication type:
    journal article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1225, doi. 10.1007/s00280-010-1410-1
    By:
    • Fracasso, Paula;
    • Williams, Kerry;
    • Chen, Ronald;
    • Picus, Joel;
    • Ma, Cynthia;
    • Ellis, Matthew;
    • Tan, Benjamin;
    • Pluard, Timothy;
    • Adkins, Douglas;
    • Naughton, Michael;
    • Rader, Janet;
    • Arquette, Matthew;
    • Fleshman, James;
    • Creekmore, Allison;
    • Goodner, Sherry;
    • Wright, Lisa;
    • Guo, Zhanfang;
    • Ryan, Christine;
    • Tao, Yu;
    • Soares, Eliane
    Publication type:
    Article
    14

    Dynamic host immune response in virus-associated cancers.

    Published in:
    Communications Biology, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1038/s42003-019-0352-3
    By:
    • Cao, Song;
    • Wylie, Kristine M.;
    • Wyczalkowski, Matt A.;
    • Karpova, Alla;
    • Ley, Jessica;
    • Sun, Sam;
    • Mashl, R. Jay;
    • Liang, Wen-Wei;
    • Wang, Xiaowei;
    • Johnson, Kimberly;
    • DiPersio, John F.;
    • Gay, Hiram;
    • Ratner, Lee;
    • Chen, Feng;
    • Adkins, Douglas R.;
    • Ding, Li
    Publication type:
    Article
    15

    Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.

    Published in:
    Rare Tumors, 2021, p. 1, doi. 10.1177/20363613211052498
    By:
    • Van Tine, Brian A;
    • Weiss, Mia C;
    • Hirbe, Angela C;
    • Oppelt, Peter J;
    • Abaricia, Sarah;
    • Trinkaus, Kathryn;
    • Luo, Jingqin;
    • Berry, Shellie;
    • Ruff, Tyler;
    • Callahan, Cheryl;
    • Toensikoetter, Jacqui;
    • Ley, Jessica;
    • Siegel, Marilyn J;
    • Dehdashti, Farrokh;
    • Siegel, Barry A;
    • Adkins, Douglas R
    Publication type:
    Article
    16

    Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.

    Published in:
    Rare Tumors, 2021, p. 1, doi. 10.1177/20363613211052498
    By:
    • Van Tine, Brian A;
    • Weiss, Mia C;
    • Hirbe, Angela C;
    • Oppelt, Peter J;
    • Abaricia, Sarah;
    • Trinkaus, Kathryn;
    • Luo, Jingqin;
    • Berry, Shellie;
    • Ruff, Tyler;
    • Callahan, Cheryl;
    • Toensikoetter, Jacqui;
    • Ley, Jessica;
    • Siegel, Marilyn J;
    • Dehdashti, Farrokh;
    • Siegel, Barry A;
    • Adkins, Douglas R
    Publication type:
    Article
    17
    18
    19
    20

    Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37266-6
    By:
    • Cotto, Kelsy C.;
    • Feng, Yang-Yang;
    • Ramu, Avinash;
    • Richters, Megan;
    • Freshour, Sharon L.;
    • Skidmore, Zachary L.;
    • Xia, Huiming;
    • McMichael, Joshua F.;
    • Kunisaki, Jason;
    • Campbell, Katie M.;
    • Chen, Timothy Hung-Po;
    • Rozycki, Emily B.;
    • Adkins, Douglas;
    • Devarakonda, Siddhartha;
    • Sankararaman, Sumithra;
    • Lin, Yiing;
    • Chapman, William C.;
    • Maher, Christopher A.;
    • Arora, Vivek;
    • Dunn, Gavin P.
    Publication type:
    Article
    21
    22

    Patterns of care and survival outcomes for laryngeal small cell cancer.

    Published in:
    Head & Neck, 2019, v. 41, n. 3, p. 722, doi. 10.1002/hed.25430
    By:
    • Lin, Alexander J.;
    • Gabani, Prashant;
    • Fischer‐Valuck, Ben;
    • Rudra, Soumon;
    • Gay, Hiram;
    • Daly, Mackenzie;
    • Oppelt, Peter;
    • Jackson, Ryan;
    • Rich, Jason;
    • Paniello, Randal;
    • Zevallos, Jose;
    • Adkins, Douglas;
    • Thorstad, Wade
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    Granulocyte–colony-stimulating factor–mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.

    Published in:
    Transfusion, 2006, v. 46, n. 1, p. 14, doi. 10.1111/j.1537-2995.2005.00665.x
    By:
    • Oza, Aarti;
    • Hallemeier, Chris;
    • Goodnough, Lawrence;
    • Khoury, Hanna;
    • Shenoy, Shalini;
    • Devine, Steven;
    • Augustin, Kristan;
    • Vij, Ravi;
    • Trinkaus, Kathryn;
    • DiPersio, John F.;
    • Adkins, Douglas
    Publication type:
    Article
    29
    30
    31

    First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors.

    Published in:
    Investigational New Drugs, 2022, v. 40, n. 5, p. 990, doi. 10.1007/s10637-022-01274-y
    By:
    • Bauer, Todd;
    • Cho, Byong Chul;
    • Heist, Rebecca;
    • Bazhenova, Lyudmila;
    • Werner, Theresa;
    • Goel, Sanjay;
    • Kim, Dong-Wan;
    • Adkins, Douglas;
    • Carvajal, Richard D.;
    • Alva, Ajjai;
    • Eaton, Keith;
    • Wang, Judy;
    • Liu, Yong;
    • Yan, Xiaohong;
    • Christensen, Jamie;
    • Neuteboom, Saskia;
    • Chao, Richard;
    • Pant, Shubham
    Publication type:
    Article
    32

    Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.

    Published in:
    Thyroid, 2024, v. 34, n. 1, p. 26, doi. 10.1089/thy.2023.0363
    By:
    • Subbiah, Vivek;
    • Hu, Mimi I.;
    • Mansfield, Aaron S.;
    • Taylor, Matthew H.;
    • Schuler, Martin;
    • Zhu, Viola W.;
    • Hadoux, Julien;
    • Curigliano, Giuseppe;
    • Wirth, Lori;
    • Gainor, Justin F.;
    • Alonso, Guzman;
    • Adkins, Douglas;
    • Godbert, Yann;
    • Ahn, Myung-Ju;
    • Cassier, Philippe A.;
    • Cho, Byoung Chul;
    • Lin, Chia-Chi;
    • Zalutskaya, Alena;
    • Barata, Teresa;
    • Trask, Peter
    Publication type:
    Article
    33

    An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer.

    Published in:
    Thyroid, 2020, v. 30, n. 9, p. 1254, doi. 10.1089/thy.2019.0269
    By:
    • Bible, Keith C.;
    • Menefee, Michael E.;
    • Lin, Chia-Chi (Josh);
    • Millward, Michael J.;
    • Maples, William J.;
    • Goh, Boon Cher;
    • Karlin, Nina J.;
    • Kane, Madeleine A.;
    • Adkins, Douglas R.;
    • Molina, Julian R.;
    • Donehower, Ross C.;
    • Lim, Wan-Teck;
    • Flynn, Patrick J.;
    • Richardson, Ronald L.;
    • Traynor, Anne M.;
    • Rubin, Joseph;
    • LoRusso, Patricia M.;
    • Smallridge, Robert C.;
    • Burton, Jill K.;
    • Suman, Vera J.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39

    Head and neck carcinoma in the United States.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 23, p. 5783, doi. 10.1002/cncr.27609
    By:
    • Ang, K. Kian;
    • Chen, Amy;
    • Curran, Walter J.;
    • Garden, Adam S.;
    • Harari, Paul M.;
    • Murphy, Barbara A.;
    • Wong, Stuart J.;
    • Bellm, Lisa A.;
    • Schwartz, Marc;
    • Newman, Jason;
    • Adkins, Douglas;
    • Hayes, D. Neil;
    • Parvathaneni, Upendra;
    • Brachman, David;
    • Ghabach, Bassam;
    • Schneider, Charles J.;
    • Greenberg, Michael;
    • Anné, Pramila R.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    T cell subtype profiling measures exhaustion and predicts anti-PD-1 response.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05474-7
    By:
    • Schillebeeckx, Ian;
    • Earls, Jon;
    • Flanagan, Kevin C.;
    • Hiken, Jeffrey;
    • Bode, Alex;
    • Armstrong, Jon R.;
    • Messina, David N.;
    • Adkins, Douglas;
    • Ley, Jessica;
    • Alborelli, Ilaria;
    • Jermann, Philip;
    • Glasscock, Jarret I.
    Publication type:
    Article